The abundance and function of biotin-dependent enzymes are reduced in rats chronically administered carbamazepine.
The effect of dietary antiepileptic drug administration on the metabolism and function of the water-soluble vitamin biotin was analyzed in a physiologically relevant rat model of biotin nutriture. Administration of carbamazepine (CBZ) in semipurified rat diet at 1.5 and 2.9 g/kg for 19 d did not reduce growth rate or food intake. After this dietary treatment, brain lactic acid and ammonia concentrations were significantly elevated, but no changes in these metabolites occurred in the liver. Urinary biotin excretion was altered and the concentrations of biotin sulfoxides and biocytin in the serum were elevated. Brain biotin was unaffected, but concentrations of bisnorbiotin and biocytin were significantly reduced by dietary administration of CBZ. The relative abundance of hepatic acetyl CoA carboxylase 1 and 2, pyruvate carboxylase (PC), methylcrotonyl CoA carboxylase and propionyl CoA carboxylase was significantly reduced by CBZ, whereas the relative abundance of biotinylated PC was significantly reduced in the brain. In agreement with the carboxylase abundance data, the activity of hepatic PC was significantly reduced in rats consuming CBZ-containing diets. These data demonstrate that administration of the antiepileptic medication CBZ, even with food, reduces the abundance and function of biotin-dependent enzymes in the liver and brain, partially accounting for the metabolic alterations, including organic acidemia, that are observed clinically.
Rathman
Sara C
SC
Center for Nutritional Sciences, Food Science and Human Nutrition Department, Institute of Food and Agricultural Sciences , University of Florida, Gainesville, FL 32611, USA.
Eisenschenk
Stephen
S
McMahon
Robert J
RJ
D000103:Acetyl-CoA Carboxylase / Q000032:analysis / Q000378:metabolism; D000641:Ammonia / Q000378:metabolism; D000818:Animals; D000927:Anticonvulsants / Q000008:administration & dosage*; D001710:Biotin / Q000031:analogs & derivatives* / Q000097:blood / Q000378:metabolism / Q000494:pharmacology* / Q000502:physiology / Q000652:urine; D019921:Biotinylation; D001921:Brain / Q000201:enzymology* / Q000378:metabolism; D002220:Carbamazepine / Q000008:administration & dosage*; D019735:Carbon-Carbon Ligases / Q000032:analysis / Q000378:metabolism; D004032:Diet; D004347:Drug Interactions; D019344:Lactic Acid / Q000378:metabolism; D008099:Liver / Q000201:enzymology* / Q000378:metabolism; D008239:Lysine / Q000031:analogs & derivatives* / Q000097:blood; D008297:Male; D011766:Pyruvate Carboxylase / Q000032:analysis / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley
D000927:Anticonvulsants; C002143:bisnorbiotin; D002220:Carbamazepine; D019344:Lactic Acid; D001710:Biotin; D000641:Ammonia; D019735:Carbon-Carbon Ligases; D011766:Pyruvate Carboxylase; D000103:Acetyl-CoA Carboxylase; C022458:propionyl CoA carboxylase (ATP-hydrolyzing); C021573:methylcrotonoyl-CoA carboxylase; C013411:biocytin; C017072:D-biotin-d-sulfoxide; D008239:Lysine